These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23551988)

  • 41. Hypersensitivity to cutaneous thermal nociceptive stimuli in irritable bowel syndrome.
    Rodrigues AC; Nicholas Verne G; Schmidt S; Mauderli AP
    Pain; 2005 May; 115(1-2):5-11. PubMed ID: 15836964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of trigeminal and spinal modulation of pain and nociception.
    Rehberg B; Baars JH; Kotsch J; Koppe P; von Dincklage F
    Int J Neurosci; 2012 Jun; 122(6):298-304. PubMed ID: 22225522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls.
    Villanueva L; Le Bars D
    Biol Res; 1995; 28(1):113-25. PubMed ID: 8728826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Widespread hyperalgesia in adolescents with symptoms of irritable bowel syndrome: results from a large population-based study.
    Stabell N; Stubhaug A; Flægstad T; Mayer E; Naliboff BD; Nielsen CS
    J Pain; 2014 Sep; 15(9):898-906. PubMed ID: 24905280
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients.
    Chalaye P; Goffaux P; Bourgault P; Lafrenaye S; Devroede G; Watier A; Marchand S
    Clin J Pain; 2012 Jul; 28(6):519-26. PubMed ID: 22673485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli. Probable involvement of a supraspinal loop.
    Roby-Brami A; Bussel B; Willer JC; Le Bars D
    Brain; 1987 Dec; 110 ( Pt 6)():1497-508. PubMed ID: 2448000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased attentional network functioning related to symptom severity measures in females with irritable bowel syndrome.
    Hubbard CS; Hong J; Jiang Z; Ebrat B; Suyenobu B; Smith S; Heendeniya N; Naliboff BD; Tillisch K; Mayer EA; Labus JS
    Neurogastroenterol Motil; 2015 Sep; 27(9):1282-94. PubMed ID: 26087779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between symptoms and hypersensitivity to rectal distension in patients with irritable bowel syndrome.
    Kuiken SD; Lindeboom R; Tytgat GN; Boeckxstaens GE
    Aliment Pharmacol Ther; 2005 Jul; 22(2):157-64. PubMed ID: 16011674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Absence of increasing cortical fMRI activity volume in response to increasing visceral stimulation in IBS patients.
    Sidhu H; Kern M; Shaker R
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G425-35. PubMed ID: 15246969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff.
    Ludidi S; Conchillo JM; Keszthelyi D; Van Avesaat M; Kruimel JW; Jonkers DM; Masclee AA
    Neurogastroenterol Motil; 2012 Aug; 24(8):729-33, e345-6. PubMed ID: 22591192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
    Király A; Csizmadia C; Illés A; Undi S
    Orv Hetil; 2006 Mar; 147(9):421-6. PubMed ID: 16619961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome.
    Wilder-Smith CH; Robert-Yap J
    World J Gastroenterol; 2007 Jul; 13(27):3699-704. PubMed ID: 17659729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The balancing act: endogenous modulation of pain in functional gastrointestinal disorders.
    Wilder-Smith CH
    Gut; 2011 Nov; 60(11):1589-99. PubMed ID: 21768212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal spinal cord pain processing in Huntington's disease. The role of the diffuse noxious inhibitory control.
    Perrotta A; Serpino C; Cormio C; Serrao M; Sandrini G; Pierelli F; de Tommaso M
    Clin Neurophysiol; 2012 Aug; 123(8):1624-30. PubMed ID: 22341978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intolerance to visceral distension in functional dyspepsia or irritable bowel syndrome: an organ specific defect or a pan intestinal dysregulation?
    Bouin M; Lupien F; Riberdy M; Boivin M; Plourde V; Poitras P
    Neurogastroenterol Motil; 2004 Jun; 16(3):311-4. PubMed ID: 15198653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expectations modulate heterotopic noxious counter-stimulation analgesia.
    Cormier S; Piché M; Rainville P
    J Pain; 2013 Feb; 14(2):114-25. PubMed ID: 23260452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Brain responses to visceral and somatic stimuli in irritable bowel syndrome: a central nervous system disorder?
    Chang L
    Gastroenterol Clin North Am; 2005 Jun; 34(2):271-9. PubMed ID: 15862935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gender-related differences in visceral perception in health and irritable bowel syndrome.
    Kim HS; Rhee PL; Park J; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Feb; 21(2):468-73. PubMed ID: 16509877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors.
    Blankstein U; Chen J; Diamant NE; Davis KD
    Gastroenterology; 2010 May; 138(5):1783-9. PubMed ID: 20045701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Basal μ-opioid receptor availability in the amygdala predicts the inhibition of pain-related brain activity during heterotopic noxious counter-stimulation.
    Piché M; Watanabe N; Sakata M; Oda K; Toyohara J; Ishii K; Ishiwata K; Hotta H
    Neurosci Res; 2014; 81-82():78-84. PubMed ID: 24583336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.